Search

everythinglearnresearchcommunity

for

Search:↓

The guide recommends specific methods for diagnosing PCOS and various treatments for its symptoms, while considering the health impacts on adolescents.

Mostly postmenopausal Caucasian women get Frontal Fibrosing Alopecia, which often includes eyebrow loss and has limited treatment success.

Cepharanthine is a well-tolerated drug with multiple medical uses, including anti-inflammatory and anti-cancer properties.

Diffuse alopecia in women may be related to androgens and iron deficiency, and basic hormone and nutrient screening is useful.

Anti-angiogenic therapy can help treat cancer but may cause resistance and side effects, so alternative methods are being explored.

Hair ages due to genetics and environmental factors, leading to graying and thinning, with treatments available for some conditions.

PCOS is a common hormonal disorder in women, treated with lifestyle changes and medications like hormonal contraceptives and metformin.

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

Androgens significantly affect female hair loss, and hormonal treatments may help.

Lifestyle changes are the main treatment for PCOS, which is a complex condition requiring early management to reduce its health impacts.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Diagnose and manage CCCA with thorough history, exams, and labs; treat with anti-inflammatory agents, stress reduction, and stopping harmful hair practices.

Vegetarian Indian women with PCOS have higher inflammation levels than non-vegetarians.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

Genes linked to fibrosis are more active in people with central centrifugal cicatricial alopecia.

People with Lichen planopilaris are more likely to have certain autoimmune and endocrine disorders but less likely to have conditions like allergies and diabetes.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

Spironolactone may help reduce hair loss in androgenic alopecia.

Women with AGA have more androstenedione and dihydrotestosterone, less copper and zinc; copper imbalance affects AGA; treatment improves hormones and minerals.

The document concludes that more research is needed to fully understand the causes of PCOS.

Hormone imbalances can cause skin diseases, and understanding these links is important for diagnosis and treatment.

New treatments for hair loss show promise, but more development is needed, especially for tough cases.

Oral isotretinoin for severe acne can change hormone levels but does not significantly affect ovarian function.

Hair loss in women can be slowed with treatment, but more research needed for better solutions.

Hormonal treatments can change hair and skin in transgender people, but may not fully achieve desired results.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Brodalumab effectively treated a man's severe hand and foot psoriasis.

Longer GGN repeats in the androgen receptor gene are linked to polycystic ovary syndrome.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.